The European Patent System: Dealing with emerging technologies.

Evisa Kica, Nico Groenendijk

Research output: Contribution to journalArticleAcademicpeer-review

6 Citations (Scopus)


In light of recent controversial patent decisions in biotechnology, this article argues that the current European patent examination and opposition procedures do not suffice to balance the patent system These procedures do not provide sufficient guidance for patent examiners to deal effectively with the emerging life science technologies. The European Patent Office needs to instill more self-reflection into the patent system and foster interaction between the Office and patent stakeholders. In this respect, we propose that the EPO should establish an ex-ante, patent-granting advisory body that would consist of multidisciplinary staff drawn from various technical fields, and collaborate closely with the scientific community and other national bodies. It is expected that such an advisory body would provide an input to the existing patent system, since it would anticipate, control and reduce the possibility that patent examiners would issue low-quality patents with huge socio-economic consequences.
Original languageEnglish
Pages (from-to)85-105
JournalInnovation : the European journal of social science research
Issue number1-2
Publication statusPublished - 2011


  • METIS-278958
  • third-party participation
  • biotechnology
  • patentassessment
  • patent prosecution
  • European patent system
  • IR-77833


Dive into the research topics of 'The European Patent System: Dealing with emerging technologies.'. Together they form a unique fingerprint.

Cite this